Remdesivir

4 trials 3 recruiting JAnti-infectives

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

3 Recruiting

0 Completed trials

5 Sponsors

11 Countries

Phase III

Phase II

Phase III: 1 Phase II: 3

Oversight events:

2 temporary halts across 1 trial

View oversight register →

Indications tested

Sponsors using this IMP

Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocion De La Salud Y La C 1 Inserm 1 Pfizer Inc. 1 Region Vaesterbotten 1 Umea University 1

All trials

4 total

Randomized Open Label Trial Evaluating Efficacy and Safety of Intravenous Immunoglobulin (IVIg, Privigen) as Add-on to SoC Versus SoC Alone … Pending

2025-522756-97-00 Phase II 1 country Region Vaesterbotten; Umea University
A Study to Learn About a Study Medicine Called Ibuzatrelvir in People With Coronavirus Disease 2019 (COVID-19) and a Severely Compromised Im… Recruiting

2024-517671-21-00 Phase III 9 countries Pfizer Inc.
Safety and Effectiveness of a 10-Day Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients with Mild or No Symptoms:… Recruiting

2024-519272-96-00 Phase II 1 country Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocio…
OPtimisation of antiviral Therapy in Immunocompromised COVID-19 patients: a randomized factorial controlled strategy trial: the OPTICOV Stud… Recruiting

2022-501408-81-01 Phase II 3 countries Inserm

Showing 1–4 of 4 trials

← All drugs A–Z